SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,095.48 |
| Enterprise Value ($M) | 1,545.73 |
| Book Value ($M) | 732.30 |
| Book Value / Share | 15.37 |
| Price / Book | 1.50 |
| NCAV ($M) | -311.10 |
| NCAV / Share | -6.53 |
| Price / NCAV | -3.52 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.12 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.19 |
| Current Ratio | 3.07 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 534.07 |
| Assets | 1,577.47 |
| Liabilities | 845.17 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 731.97 |
| Operating Income | 205.42 |
| Net Income | 159.52 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 213.39 |
| Cash from Investing | -124.93 |
| Cash from Financing | -80.95 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Zhang Jack Y. | 24.80 | -6.78 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 155,309 | 627,777 | 24.74 | |
| 239,213 | 811,138 | 29.49 | |
| 217,333 | 653,789 | 33.24 | |
| 99,748 | 423,723 | 23.54 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALXO – ALX Oncology Holdings Inc. | AMGN – Amgen Inc. |
| AMLX – Amylyx Pharmaceuticals, Inc. | AMRX – Amneal Pharmaceuticals, Inc. |
| ANAB – AnaptysBio, Inc. |
Financial data and stock pages provided by
Fintel.io